摘要：在追求真理与科学发展的学术殿堂中，一股不容忽视的暗流正在悄然涌动。这股暗流，便是学术界中的学阀与利益集团。他们以权力、资源、影响力为武器，垄断学术资源，控制学术评价，排挤异己，形成了一个个封闭的学术圈子。这股现象在医学界尤为突出，其危害更是深远而广泛，涉及科研

在追求真理与科学发展的学术殿堂中，一股不容忽视的暗流正在悄然涌动。这股暗流，便是学术界中的学阀与利益集团。他们以权力、资源、影响力为武器，垄断学术资源，控制学术评价，排挤异己，形成了一个个封闭的学术圈子。这股现象在医学界尤为突出，其危害更是深远而广泛，涉及科研、临床、学术创新以及医生职务晋升等多个方面。

一、科研领域的阴霾

在医学科研领域，学阀与利益集团通过掌控科研项目、评审资金分配等环节，严重扭曲了科研的初衷和方向。他们往往以“科研至上”为幌子，大肆追求论文数量而非质量，导致大量科研经费被浪费在低水平的重复研究上。例如，我国每年的医学科研经费有相当一部分被用于发表外文论文，而这些论文往往缺乏实质性的临床价值和创新性。更为严重的是，一些学阀通过学术造假、买卖文章等手段，进一步巩固了他们的学术地位，而真正有才华的科研人员却难以获得应有的支持和认可。

二、临床实践的困境

在临床实践方面，学阀与利益集团的危害同样触目惊心。他们往往通过控制医院的管理层和科研方向，使得临床医生在繁忙的工作中难以兼顾科研。这不仅削弱了医生的临床技能，还导致了医疗质量的下降。更为严重的是，一些学阀为了追求个人利益，不惜牺牲患者的利益，将患者当作试验品来练手，造成了许多不必要的悲剧。例如，在某些医院中，年轻的医生在晋升副主任医师之前，往往需要在实验室中度过漫长的岁月，而他们的临床技能却得不到应有的锻炼和提升。一旦他们走上临床岗位，往往会因为缺乏经验而给患者带来风险。

三、学术创新的阻碍

学术创新是推动医学发展的关键动力。然而，在学阀与利益集团的掌控下，学术创新却受到了严重的阻碍。他们往往通过控制学术评价和人才选拔等环节，排斥那些敢于挑战传统、提出新观点的科研人员。这导致了许多有潜力的科研项目和人才被埋没和浪费。更为严重的是，这种排斥和压制还形成了一种负面的学术氛围，使得科研人员不敢轻易尝试新的研究方向和方法，从而阻碍了医学的进步和发展。

四、医生职务晋升的畸形

在医生职务晋升方面，学阀与利益集团的影响同样不可忽视。他们通过控制职称评审的流程和标准，使得那些与他们关系密切、符合他们利益的人更容易获得晋升的机会。而那些真正有才华、有贡献的医生却往往因为缺乏“关系”和“背景”而被排斥在晋升的门外。这种畸形的职务晋升制度不仅挫伤了医生的积极性和创造力，还导致了医疗队伍的不稳定和人才流失。

以中山二院宋某某院士实验室风波以及心内科专家胡某一对某勇教授的实名举报为例，这些事件不仅揭示了医学学术领域中的腐败和不公，更引发了人们对医学界未来发展的深刻担忧。在这些事件中，我们可以看到学阀与利益集团如何通过各种手段来维护自己的地位和利益，而真正有才华和贡献的科研人员却难以获得应有的认可和支持。

综上所述，学阀与利益集团在医学界的危害是多方面的、深远的。他们不仅扭曲了科研的初衷和方向，削弱了医生的临床技能，阻碍了学术创新的发展，还破坏了医生职务晋升的公正性和合理性。为了改变这种现状，我们需要从制度层面入手，加强学术评价和人才选拔的公正性和透明度，打破学阀与利益集团的垄断和控制，为真正有才华和贡献的科研人员提供更多的支持和机会。只有这样，我们才能推动医学事业的健康发展，造福更多的患者和社会。

作者简介：梁世杰 中医高年资主治医师，从事中医临床工作24年，积累了较丰富的临床经验。师从首都医科大学附属北京中医院肝病科主任医师、著名老中医陈勇，侍诊多载，深得器重，尽得真传！擅用“商汤经方分类疗法”、专病专方结合“焦树德学术思想”“关幼波十纲辨证”学术思想治疗疑难杂症为特色。现任北京厚德为怀医生集团渐冻症研究中心主任，北京树德堂中医研究院研究员，北京中医药薪火传承新3+3工程—焦树德门人（陈勇）传承工作站研究员，国际易联易学与养生专委会常务理事，中国中医药研究促进会焦树德学术传承专业委员会委员，中国药文化研究会中医药慢病防治分会首批癌症领域入库专家。荣获2020年中国中医药研究促进会仲景医学分会举办的第八届医圣仲景南阳论坛“经方名医”荣誉称号。2023年首届京津冀“扁鹊杯”燕赵医学研究主题征文优秀奖获得者。事迹荣登2024年第四季刊《当代科学家》杂志。

The Mystery of Academia: The Harmful Consequences of Scholarism and Interest Groups - Medicine as an example

In the academic hall of pursuit of truth and scientific development, an undercurrent cannot be ignored is quietly welling up. This undercurrent is the academic establishment and interest groups. Using power, resources, and influence as weapons, they monopolize academic resources, control academic evaluation, and marginalize dissent, forming closed academic circles. This phenomenon is particularly prominent in the medical profession, and its harm is far-reaching and widespread, involving research, clinical, academic innovation, and physician promotion.

I. Smog in the field of scientific research

In the field of medical research, charlatans and interest groups have seriously distorted the original intention and direction of research by controlling research projects and reviewing the allocation of funds. They often pursue the number of papers rather than the quality under the guise of "research primacy," resulting in a huge amount of research funding being wasted on low-level repetitive research. For example, a significant portion of China's annual medical research funding is spent on the publication of foreign-language papers, which often lack substantial clinical value and innovation. More seriously, some research entities have further consolidated their academic status through academic fraud and the sale of articles, while truly talented researchers have difficulty obtaining the support and recognition they deserve.

II. The dilemma of clinical practice

In clinical practice, the dangers of academic valves and interest groups are just as alarming. They often control hospital management and research direction, making it difficult for clinicians to juggle research during their busy work. This not only weakens the clinical skills of doctors, but also leads to a decline in the quality of care. Even more serious is that some learners, in pursuit of their personal interests, will not hesitate to sacrifice the interests of the patients, and use the patients as test subjects to practice their skills, causing many unnecessary tragedies. In some hospitals, for example, young doctors often spend long years in the laboratory before being promoted to associate physician, without the exercise and upgrading of their clinical skills. Once they get into clinical roles, they often put patients at risk because of their lack of experience.

III. Obstacles to Academic Innovation

Academic innovation is a key driver of medical development. Academic innovation, however, is severely hampered by the control of academic bubbles and interest groups. They often exclude researchers who dare to challenge tradition and propose new ideas by controlling aspects such as academic evaluation and talent selection. This has led to many promising research projects and talent being buried and wasted. More seriously, this exclusion and repression also creates a negative academic climate that prevents researchers from easily trying new research directions and methods, thus hindering the progress and development of medicine.

IV. The abnormality of the promotion of doctors

When it comes to the promotion of doctors, the influence of academics and interest groups cannot be ignored. By controlling job title review processes and standards, they make it easier for those close to them and in their interests to get promoted. And those who are truly talented and contributing doctors are often excluded from promotion because of a lack of "connections" and "background." This dysfunctional system of job promotion not only undermines the motivation and creativity of doctors, but also leads to instability and a brain drain in the medical workforce.

Take the disturbance in the lab of academician Song Moumou of Zhongshan Second Hospital and the real-name report of cardiologist Hu Moumou to Professor Mouyong as an example. These incidents not only reveal the corruption and injustice in the medical academic field, but also arouse people's deep concern about the future development of the medical field. In these events, we can see how the academic valves and interest groups use various means to maintain their position and interests, while truly talented and contributing researchers struggle to get the recognition and support they deserve.

In summary, the dangers of academic valves and interest groups in the medical profession are multifaceted and far-reaching. They not only distort the original intent and direction of scientific research, weaken physicians' clinical skills, hinder the development of academic innovation, and undermine the fairness and rationality of physician promotion. To change this situation, we need to take a systemic approach, strengthen the fairness and transparency of academic evaluation and talent selection, break the monopoly and control of research entities and interest groups, and provide more support and opportunities for truly talented and contributing researchers. Only in this way can we promote the healthy development of the medical profession for the benefit of more patients and society.

Author Bio: Liang Shijie is a senior medical practitioner in traditional Chinese medicine. He has been engaged in traditional medicine clinical work for 24 years and has accumulated a wealth of clinical experience. Following Chen Yong, chief physician of liver disease at Beijing Traditional Medicine Hospital, affiliated with Capital Medical University, and renowned old Chinese medicine, he has been treated for many years and received great attention. He specializes in the treatment of difficult diseases using "conversational traditional therapy" and special treatments combined with the academic ideas of Jiao Shude and Guan Yubo's ten-level diagnosis.He is currently the director of the Center for Diffusion Research of Dr. Houde Wei Group in Beijing, a researcher at the Shude Tang Institute of Chinese Medicine, and a fellow at the new 3 + 3 project of traditional Chinese medicine flame inheritance in Beijing - a scholar at the inheritance work station of Jiao Shude's protégés (Chen Yong),He is a standing committee member of the International Expert Committee on E-learning and Health Care, a member of the Jiao Shude Academic Heritage Special Committee of the Chinese Association for the Advancement of Chinese Medicine Research, and the first cancer specialist to be included in the chapter of the Chinese Pharmaceutical Culture Research Association. Won the 2020 China Association for the Promotion of Traditional Chinese Medicine Zhongjing Medical Branch held the eighth session of the Medical Saint Zhongjing Nanyang Forum "Classic Prescription Famous Doctor" honorary title. The winner of the first Beijing-Tianjin-Hebei "Pingui Cup" Yanzhao Medical Research Essay Award in 2023. The story was featured in the fourth edition of Current Scientist in 2024.

来源：首都专家梁世杰